Specifications Manual for Joint Commission National Quality Measures (v2020B1)
Posted: 3/30/2020
Home » Reason for No Administration of VTE Prophylaxis

Release Notes:
Data Element
Version 2020B1

Name:Reason for No Administration of VTE Prophylaxis
Collected For: VTE-6
Definition:Physician/APN/PA or pharmacist documentation why mechanical AND pharmacological VTE prophylaxis were not administered on the day(s) between arrival and the day before the VTE Diagnostic Test order date. Both mechanical and pharmacological prophylaxis must be addressed.
Question:Is there physician/APN/PA or pharmacist documentation why VTE prophylaxis was not administered on the day(s) between arrival and the day before the VTE Diagnostic Test order date?
Format:
Length:1
Type:Alphanumeric
Occurs:1
Allowable Values:

Y (Yes)     There is physician/APN/PA or pharmacist documentation why mechanical AND pharmacological VTE prophylaxis were not administered on the day(s) between arrival and the day before the VTE Diagnostic Test order date.

N (No)     There is no physician/APN/PA or pharmacist documentation why mechanical AND pharmacological VTE prophylaxis were not administered on the day(s) between arrival and the day before the VTE Diagnostic Test order date, or unable to determine from medical record documentation.
Notes for Abstraction:
  • To select “Yes” for this data element, documentation of a reason for not administering mechanical AND pharmacological VTE prophylaxis must be dated between hospital arrival and the day before the VTE Diagnostic Test order date. Refer to the data element VTE Diagnostic Test for a list of acceptable tests.
  • Reasons for not prescribing VTE prophylaxis must be documented by a physician/APN/PA or pharmacist.
    EXCEPTIONS:
    • Patient/family refusal may be documented by a nurse, but should be documented within the same time frame as the reason for no VTE prophylaxis. Patient/family refusal of any form of prophylaxis is acceptable to select “Yes.” For example, “patient refused heparin,” select “Yes.”
    • A validated risk assessment may be documented by a nurse, but should be documented within the same time frame as the reason for no administration of VTE prophylaxis.
    • For patients receiving anticoagulant therapy, including continuous IV heparin infusion, between arrival and the day before the VTE diagnostic test order date, select “Yes.” Disregard IV heparin administered to flush/maintain patency of a line or dialysis equipment and IV heparin administered during an interventional procedure, e.g., cardiac cath.
  • If reasons are not mentioned in the context of VTE prophylaxis, do not make inferences (e.g., do not assume that VTE Prophylaxis was not administered because of a bleeding disorder unless documentation explicitly states so).
    Example:
Physician/APN/PA documentation of bleeding risk, review the chart for documentation about reasons for no mechanical AND no pharmacological VTE prophylaxis.
  • Documentation that a formal risk assessment was administered, AND the results indicated that there was no risk or low risk for VTE is acceptable as a reason for not administering VTE prophylaxis.
    • If a copy of the validated risk assessment is included in the medical record along with the results, select “Yes.”
    • Documentation of a low risk score without a copy of the validated risk assessment is acceptable, if the validated risk assessment tool used is mentioned in the note. See Inclusion Guidelines for Abstraction.
    • Documentation of low risk or no risk without mention of a score and the validated risk assessment tool, select “No.”
  • If two physicians/APN/PA or pharmacist document conflicting or questionable needs for prophylaxis, select “No.”
Suggested Data Sources: ONLY PHYSICIAN/APN/PA OR PHARMACIST DOCUMENTATION OF A REASON FOR NOT ADMINISTERING VTE PROPHYLAXIS
  • Anesthesia record
  • Consultation notes
  • Emergency department record
  • History and physical
  • Physician orders
  • Physician progress notes
  • Transfer form

SUGGESTED DATA SOURCES FOR PATIENT REFUSAL (other than physician/APN/PA or pharmacist) documentation of a reason for not administering VTE prophylaxis as above):
  • Medication administration record
  • Nurses notes
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
Explicit documentation that the patient does not need VTE prophylaxis

ALL INCLUSIVE VALIDATED RISK ASSESSMENTS:
  • Caprini DVT Risk Assessment
  • Padua Prediction Score
  • International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)

LOW RISK SCORES:
  • Caprini score of 0 (zero) – no need for prophylaxis.
  • IMPROVE score of 0 (zero) or 1 (one); or a probability of less than 1.5%
  • Padua score of less than 4 (0-3)

Refer to Appendix H, Table 2.7 Anticoagulation Therapy
Risk Assessment tools other than Caprini, Padua, and IMPROVE

Reason for No Administration of VTE Prophylaxis
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2020B1)
Discharges 07-01-20 (3Q20) through 12-31-20 (4Q20)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^